| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/28/2023 | 79.95% | Stifel | → $7 | Initiates Coverage On | → Buy |
| 08/25/2023 | 54.24% | Rosenblatt | → $6 | Reiterates | Buy → Buy |
| 08/11/2023 | — | Jefferies | Upgrades | Underperform → Hold | |
| 08/10/2023 | 18.25% | Morgan Stanley | $5 → $4.6 | Maintains | Equal-Weight |
| 08/10/2023 | 54.24% | Rosenblatt | $8.5 → $6 | Maintains | Buy |
| 08/10/2023 | 157.07% | Needham | $15 → $10 | Maintains | Strong Buy |
| 08/03/2023 | 28.53% | Morgan Stanley | $7.5 → $5 | Maintains | Equal-Weight |
| 07/10/2023 | 118.51% | Rosenblatt | → $8.5 | Reiterates | Buy → Buy |
| 05/04/2023 | 54.24% | Northland Capital Markets | $7 → $6 | Maintains | Market Perform |
| 05/04/2023 | 285.6% | Needham | → $15 | Reiterates | → Strong Buy |
| 03/13/2023 | 285.6% | Needham | → $15 | Reiterates | → Strong Buy |
| 03/09/2023 | 92.8% | Morgan Stanley | $7 → $7.5 | Maintains | Equal-Weight |
| 02/24/2023 | 79.95% | Morgan Stanley | $6 → $7 | Maintains | Equal-Weight |
| 02/24/2023 | 131.36% | Rosenblatt | → $9 | Reiterates | → Buy |
| 02/24/2023 | 285.6% | Needham | → $15 | Reiterates | → Strong Buy |
| 11/03/2022 | 54.24% | Morgan Stanley | $5 → $6 | Maintains | Equal-Weight |
| 10/11/2022 | 28.53% | Morgan Stanley | $7.5 → $5 | Maintains | Equal-Weight |
| 08/05/2022 | 131.36% | MKM Partners | → $9 | Assumes | → Buy |
| 07/14/2022 | 67.1% | JP Morgan | $7.5 → $6.5 | Maintains | Underweight |
| 05/04/2022 | 92.8% | Morgan Stanley | $8 → $7.5 | Maintains | Equal-Weight |
| 05/04/2022 | 182.78% | B. Riley Securities | $12.5 → $11 | Maintains | Buy |
| 05/04/2022 | 131.36% | Citigroup | $10.5 → $9 | Maintains | Neutral |
| 03/24/2022 | 208.48% | Rosenblatt | → $12 | Initiates Coverage On | → Buy |
| 01/24/2022 | 195.63% | B. Riley Securities | $10 → $11.5 | Upgrades | Neutral → Buy |
| 10/18/2021 | 131.36% | JP Morgan | $11 → $9 | Downgrades | Neutral → Underweight |
| 09/24/2021 | — | MKM Partners | Downgrades | Buy → Neutral | |
| 05/13/2021 | 157.07% | Wolfe Research | → $10 | Upgrades | Underperform → Peer Perform |
| 05/05/2021 | 79.95% | Northland Capital Markets | $6 → $7 | Maintains | Market Perform |
| 02/10/2021 | 208.48% | Rosenblatt | $9 → $12 | Maintains | Buy |
| 08/17/2020 | 208.48% | Stifel | → $12 | Upgrades | Hold → Buy |
| 08/06/2020 | 105.66% | Morgan Stanley | $5 → $8 | Maintains | Equal-Weight |
| 08/06/2020 | 79.95% | Citigroup | $4 → $7 | Maintains | Sell |
| 08/06/2020 | 169.92% | Rosenblatt | → $10.5 | Upgrades | Neutral → Buy |
| 08/06/2020 | 285.6% | Needham | $12 → $15 | Maintains | Strong Buy |
| 07/24/2020 | 54.24% | Wolfe Research | → $6 | Initiates Coverage On | → Underperform |
| 06/19/2020 | 118.51% | MKM Partners | $7.5 → $8.5 | Maintains | Buy |
| 05/13/2020 | 28.53% | Northland Capital Markets | $9 → $5 | Downgrades | Outperform → Market Perform |
| 05/13/2020 | -22.88% | Jefferies | $3.5 → $3 | Maintains | Underperform |
| 05/13/2020 | 144.22% | B. Riley Securities | $11 → $9.5 | Maintains | Buy |
| 04/21/2020 | 79.95% | Rosenblatt | $8 → $7 | Maintains | Neutral |
| 04/02/2020 | 118.51% | Piper Sandler | → $8.5 | Upgrades | Neutral → Overweight |
| 03/30/2020 | 28.53% | Nomura | $6 → $5 | Maintains | Neutral |
| 03/16/2020 | -10.03% | Citigroup | $9 → $3.5 | Downgrades | Neutral → Sell |
| 02/26/2020 | 105.66% | Stifel | $7 → $8 | Maintains | Hold |
| 02/26/2020 | 169.92% | MKM Partners | $9.5 → $10.5 | Maintains | Buy |
| 02/26/2020 | 105.66% | Rosenblatt | $7 → $8 | Maintains | Neutral |
| 02/24/2020 | 208.48% | Needham | → $12 | Reiterates | → Strong Buy |
| 01/02/2020 | 208.48% | Needham | $10 → $12 | Reiterates | → Strong Buy |
| 11/13/2019 | 54.24% | Nomura | $5 → $6 | Maintains | Neutral |
| 11/13/2019 | — | JP Morgan | Upgrades | Underweight → Neutral | |
| 11/07/2019 | — | Jefferies | Downgrades | Hold → Underperform | |
| 10/01/2019 | 79.95% | MKM Partners | $6 → $7 | Maintains | Buy |
| 09/27/2019 | 105.66% | B. Riley Securities | $6.5 → $8 | Maintains | Buy |
| 08/08/2019 | — | Raymond James | Upgrades | Underperform → Market Perform | |
| 07/23/2019 | 54.24% | B. Riley Securities | $4.75 → $6 | Upgrades | Neutral → Buy |
| 06/03/2019 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 06/03/2019 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 03/11/2019 | — | MKM Partners | Upgrades | Neutral → Buy | |
| 02/25/2019 | — | MKM Partners | Upgrades | Sell → Neutral | |
| 11/13/2018 | 54.24% | Morgan Stanley | $9.5 → $6 | Downgrades | Overweight → Equal-Weight |
| 11/09/2018 | — | Jefferies | Upgrades | Underperform → Hold | |
| 11/07/2018 | 54.24% | Nomura | $12 → $6 | Downgrades | Buy → Neutral |
| 11/05/2018 | 67.1% | B. Riley Securities | $9.5 → $6.5 | Maintains | Neutral |
| 10/01/2018 | 41.39% | MKM Partners | $10 → $5.5 | Downgrades | Neutral → Sell |
What is the target price for Infinera (INFN)?
There is no price target for Infinera
What is the most recent analyst rating for Infinera (INFN)?
There is no analyst for Infinera
When is the next analyst rating going to be posted or updated for Infinera (INFN)?
There is no next analyst rating for Infinera
Is the Analyst Rating Infinera (INFN) correct?
There is no next analyst rating for Infinera